NCT05310643
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05310643
Title Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC (NIPIRESCUE)
Acronym NIPIRESCUE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Jean Minjoz RECRUITING Besançon France Details
Institute Bergonie RECRUITING Bordeaux France Details
CHRU Lille RECRUITING Lille France Details
CHU Dupuytren RECRUITING Limoges France Details
Centre Léon Bérard RECRUITING Lyon France Details
ICM Val d'Aurelle RECRUITING Montpellier France Details
Centre Antoine Lacassagne RECRUITING Nice France Details
Hôpital Saint Antoine RECRUITING Paris France Details
CHU Poitiers RECRUITING Poitiers France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field